About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the future of humanity.
Research at the Weizmann Institute of Science has led to improved health and better medicine for people everywhere. Weizmann scientists discovered the basis of amniocentesis and new fertility treatments; discovered Copaxone® and Rebif®, today two of the frontline treatments for multiple sclerosis (MS); and developed a technology used in advanced medical imaging scans. They are creating diabetes vaccines and flu vaccines; using stem cells to grow new organs and T cells to treat damaged spines; and studying the origins of life and the origins of disease. Institute scientists are also advancing into the future of medicine: at its new Nancy and Stephen Grand Israel National Center for Personalized Medicine, treatments and therapies designed for the individual patient will become a reality. From understanding the origins of disease to developing the basis for new medicines, the Institute’s basic science research is leading to a healthier world.
While studying the microbiome–the mostly good “bugs” in our gut–our scientists discovered that people can respond differently to the same food. Working with Yale, the Mayo Clinic, and Johnson & Johnson, they created an algorithm that analyzes microbiomes to craft individualized diets.
©2025 American Committee for the Weizmann Institute of Science
